The London Technology team advised Creandum on their lead investment into Lindus Health in connection with the company’s $18 million Series A round. Other investors included Peter Thiel and returning investors Seedcamp, Hambro Perks and Amino Collective.
Lindus Health provides a technology platform for health and biotech companies to execute clinical trials from start to finish.
For additional details on the financing please read Lindus Health’s press release.